Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure

NCT01646515 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped Substantial benefit was observed in the active treatment group

Conditions

Systolic Heart Failure

Interventions

DRUG: Placebo
DRUG: Udenafil (Zydena)

Sponsor

Seoul National University Hospital

Collaborators

[object Object]